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The T-box transcription factor, T-bet promotes the differentiation of short-lived effector
CD8
1 T cells at the expense of central memory cells. How T-bet mediates these effects, and
whether they are directly caused by T-bet alone are unknown, because expression of T-bet
requires stimulation of the T cell by inﬂammatory and growth cytokines, which may have
T-bet-independent functions involving T-cell differentiation. We developed an in vitro
system of ectopic T-bet expression that avoids the effects of inﬂammatory cytokines to
determine which aspects of the T-bet phenotype may be accounted for by T-bet alone.
Ectopic T-bet expression by OT-I CD8
1 T cells stimulated by the H2-Kb (SIINFEKL) complex
and cultured with 2ng/mL IL-2 induced a coordinated change in gene expression leading
to down-regulation of CD127 and SOCS-1 and up-regulation of CD122 and IL-15 receptor a,
switching the cellular survival cytokine from IL-7 to IL-15. T-bet expression and 2ng/mL
IL-2 also led to a capacity for IFN-c and Fas ligand expression, conﬁrming a role in eliciting
these effector functions. Finally, ectopic T-bet promoted the expression of B lymphocyte-
induced maturation protein 1 by OT-I cells in the presence of 20ng/mL IL-2, providing a
mechanism for the role of T-bet in driving terminal differentiation in concert with a high
level of IL-2 receptor signalling.
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Introduction
The T-box transcription factor T-bet was ﬁrst described as the
transcription factor that is responsible for the development of Th1
CD4
1 T cells [1]. Since that report, T-bet has been found to be
involved in the differentiation of several other types of immune
cells, including macrophages [2], NK cells [3] and CD8
1 T cells
[4]. Although its role in the CD8
1 T cell was initially thought to
be non-essential [5], studies have recently shown that T-bet is
involved in the differentiation of short-lived effector CD8
1 T cells
[6] at the expense of central memory cells [7], and to account
for the defect in the development of central memory CD8
1
T cells that occurs in CD4
1 T-cell-deﬁcient mice with viral
infections [7]. Some of the phenotypic aspects that distinguish
effector/effector memory CD8
1 T cells from central memory
cells that have been ascribed to T-bet are low expression of
IL-7Ra, increased responsiveness to IL-15, and a short lifespan
during acute viral infections [6]. However, which of these
responses of the CD8
1 T cell are a direct consequence of T-bet
alone or of T-bet acting in concert with other factors, such as
cytokines or other transcription factors, is not known, mainly
because the studies of T-bet function in the CD8
1 T cell have been
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easily controlled.
In considering additional signalling pathways that may
interact with T-bet, it is notable that some phenotypes of the
activated CD8
1 T cell that have been ascribed to T-bet have also
been associated with IL-2 receptor (IL-2R) signalling [8, 9] and
with expression of the zinc ﬁnger-containing transcriptional
repressor, B-lymphocyte-induced maturation protein 1 (Blimp-1)
[10, 11]. For example, two recent studies comparing WT and
IL-2Ra-deﬁcient CD8
1 T cells concluded that sustained IL-2R
signalling during an acute viral infection led to the development
of terminally differentiated effector cells in preference to central
memory cells [8, 9], which is reminiscent of the phenotype
associated with high T-bet expression [7]. Blimp-1, which may be
a master regulator of the terminal differentiation of T cells
[10, 11] as it is in B cells [12], is required for normal develop-
ment of effector CD8
1 T cells [13, 14], and its absence prevents
the occurrence of ‘‘exhausted’’ CD8
1 T cells [15] that have a
phenotype similar to that of T-bet-dependent, ‘‘unhelped’’ CD8
1
T cells [7]. Moreover, the ﬁnding that IL-2R signalling induces
expression of Blimp-1 in the CD8
1 T cell [16] may account for
these two factors being associated with similar in vivo phenotypes
of an antigen-stimulated CD8
1 T cell, but this report did not
evaluate the possible involvement of T-bet.
In this study, we developed an in vitro model system to
determine those aspects of the T-bet phenotype that may be
accounted for by T-bet alone, and whether T-bet links IL-2R
signalling to the expression of Blimp-1.
Results
We examined the effects of T-bet that was ectopically expressed
by retroviral transduction of OT-I CD8
1 T cells grown in the
presence of neutralising antibodies to IFN-g and IL-12 [17],
which are involved in endogenous T-bet expression, to enable an
analysis of T-bet-mediated developmental changes that are
independent of the effects of these two inﬂammatory cytokines.
We also controlled the concentration of IL-2 by addition of
deﬁned amounts to CD8
1 T cells that had been activated by
antigen in the absence of CD28 co-stimulation, which would
avoid cellular biosynthesis of this cytokine. By this means, we
were able to generate two populations of OT-I cells that had
identical exposures to antigen and cytokines, and differed only in
their relative expression of T-bet (Fig. 1A). Moreover, the level of
T-bet protein in the OT-I cells transduced with the T-bet-
expressing retroviral vector was similar to that of highly
differentiated, KLRG1
1CD8
1 T cells from mice persistently
infected with murine gammaherpesvirus 68 (MHV-68) (Fig.
1A). Therefore, the ﬁnding that these T-bet
1 OT-I cells
maintained in culture by the presence of low amounts of IL-2
(2ng/mL) differed from the control T-bet cells by increased
expression of CD122 and almost absent expression of CD127
(Fig. 1B) indicates that this transcription factor is sufﬁcient for
these aspects of an effector CD8
1 T cell. In addition to its
promoting the effector function of TCR-inducible IFN-g (Fig. 1B),
ectopic T-bet also caused the expression of Fas ligand (FasL)
(Fig. 2A), which was functional in that the T-bet
1 OT-I cells
mediated FasL-dependent activation-induced cell death (Fig. 2B).
Thus, T-bet and a low level of IL-2R signalling are sufﬁcient for
these aspects of effector differentiation.
The down-regulation of IL-7Ra by T-bet resembles the
phenotype of the ‘‘short-lived effector CD8
1 T cell’’ [6], and an
alternative means for long-term viability in vivo for such a cell
would be signalling via the IL-15 receptor (IL-15R). In addition to
conﬁrming the known ability of T-bet to induce CD122 [6, 18],
the IL-2/IL-15Rb subunit, we examined two other elements
controlling the IL-2/15R pathway: IL-15Ra and SOCS-1, which is
a repressor of signalling by receptors containing the g c chain.
Analysis of T-bet
1 and T-bet
 OT-I cells revealed that the former
cells had increased IL-15Ra expression (Fig. 3A), and a two-fold
reduction in SOCS-1 mRNA (Fig. 3B). These three relatively
modest changes in the expression of IL-2/15Rb, IL-15Ra and
SOCS1, together resulted in the T-bet
1 OT-I cells being much
more responsive to IL-15-dependent proliferation than were the
T-bet-cells (Fig. 3C).
As indicated in the Introduction section, the three phenotypes
of the Blimp-1-dependent, ‘‘exhausted’’ CD8
1 T cell generated
during certain persistent viral infections, the T-bet-dependent,
aberrantly differentiated CD8
1 T cell occurring in the absence of
CD4
1 T-cell help, and the CD25high CD8
1 T cell responding to a
viral infection, have shared features. Accordingly, we used our
in vitro system to determine whether T-bet and IL-2R signalling
were involved in the expression of Blimp-1. Culture of the
retrovirally transduced T-bet
1 and T-bet
 OT-I cells in the
presence of 2ng/mL IL-2 did not induce the expression of
Blimp-1. However, if culture was carried out with 20ng IL-2/mL,
which would be sufﬁcient to saturate all IL-2R, even those lacking
the IL-2Ra subunit, Blimp-1 expression increased six-fold in the
OT-I cells expressing ectopic T-bet (Fig. 4). This change in
Blimp-1 expression occurred with no apparent increase in T-bet
expression above that mediated by the pMig/T-bet/Thy1 retro-
viral vector (Supporting Information Fig. 1). Thus, T-bet links
IL-2R signalling to the expression of Blimp-1.
Discussion
This study has resolved two questions regarding T-bet: whether
its role in promoting the acquisition of effector functions by the
CD8
1 T cell is dependent on the cytokines that regulate its
expression, and how it contributes to the terminal differentiation
of the CD8
1 T cell. Introducing ectopic T-bet into the CD8
1 T cell
was the most direct means of addressing these questions, but
depended on having in vitro conditions that promoted the cell
cycling of OT-I cells, which is necessary for retroviral transduc-
tion, but did not induce expression of endogenous T-bet. We have
found that it is difﬁcult, if not impossible, to purify populations of
apparently naı ¨ve CD8
1 T cells that are devoid of IFN-g-producing
capability when stimulated by TCR ligands. Thus, although such
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Figure 1. Ectopic expression of physiological levels of T-bet in CD8
1 T cells. (A) OT-I cells that had been activated with 10nM SIINFEKL (OVA)
peptide in the presence of 2ng/mL IL-2 and neutralising antibodies to IFN-g, IFN-gR1 and IL-12 were held in buffer or transduced with pMig/Thy1 or
pMig/Thy1/T-bet. On day 2 post-transduction, rat Thy1
1 cells were MACS-isolated to greater than 98% purity and whole-cell lysates were prepared.
Additionally, whole-cell lysates were prepared from CD44
hi KLRG1
lo and CD44
hi KLRG1
hi CD8
1 T cells that had been puriﬁed from the spleens of
three to four mice 10–12wk post-infection with MHV-68. Naı ¨ve OT-I cells were used as a negative control for T-bet expression. The expression of
T-bet and b-actin were measured three times for each determination using ImageJ. The means and SD of relative T-bet expression are shown.
Results are representative of two independent experiments. Brieﬂy, p-value was calculated using a two-tailed unpaired Student’s t-test. (B) OT-I
cells were transduced with the pMig retroviruses. On day 2 post-transduction, rat Thy1
1 cells were evaluated for the expression of CD122 and
CD127 by FACS analysis. In addition, cells were stimulated with SIINFEKL peptide, 2ng/mL IL-2 and Brefeldin A for 3h and evaluated for
intracellular IFN-g. The grey areas represent isotype staining and the black lines represent speciﬁc antibody staining. The MFI (CD122) and % cells
speciﬁcally staining with anti-IFN-g and anti-CD127 are represented by the numbers in the FACS plots and histograms. Cumulative means and SE
from three to four independent experiments are presented. Brieﬂy, p-values were calculated using two-tailed paired Student’s t-tests.
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Figure 2. Ectopic expression of T-bet in CD8
1 T cells and effects on FasL expression and activation-induced cell death. (A) OT-I cells were
transduced and puriﬁed on day 2 post-transduction. RNAwas extracted and assessed for FasL mRNA by qRT-PCR relative to CD3e mRNA levels. All
RNA samples were done in triplicate and the ‘‘No RT’’ controls were negative. The means and SD are shown for each determination. Results are
representative of two independent experiments. Brieﬂy, p-value was calculated using a two-tailed unpaired Student’s t-test. (B) OT-I cells were
transduced, puriﬁed and cultured in the presence or absence of plate-bound anti-CD3, IL-2 (2ng/mL) and anti-IFN-g antibodies. Anti-FasL antibody
(20mg/mL) was added to some cells to block ligation of Fas. After 20h, cells were assessed for apoptosis by ﬂow cytometry, following staining with
Annexin Vand 7-AAD. The percentage of Annexin-Vexpressing cells was determined in the viable 7-AAD-negative population. The means and SD
are shown for each determination and results are representative of two independent experiments. Brieﬂy, p-values were determined by a one-way
analysis of variance followed by Tukey’s multiple comparison test for comparisons between all pairs of conditions.
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Figure 3. Ectopic expression of T-bet in CD8
1 T cells and regulation of IL-15R signalling. (A) OT-I cells were transduced and puriﬁed. On day 2 post-
transduction, Thy1
1 cells were evaluated for IL-15Ra expression by FACS analysis. The grey area represents isotype staining and the black line
represents speciﬁc antibody staining. The MFI for speciﬁc staining is represented by the numbers in each histogram. Cumulative means and SE of
the MFI of speciﬁc IL-15Ra staining from three independent experiments are presented in the FACS plots and histograms. Brieﬂy, p-value was
calculated using two-tailed paired Student’s t-test. (B) OT-I cells were transduced and Thy1
1 cells assessed for SOCS1 mRNA by qRT-PCR relative to
CD3e mRNA levels. All RNA samples were done in triplicate and the ‘‘No RT’’ controls were negative. Cumulative means and SD from three
independent experiments are shown. Brieﬂy, p-value was calculated using two-tailed paired Student’s t-test. (C) OT-I cells were transduced,
puriﬁed and plated at 510
5 cells/well with 20ng/mL IL-15 in the presence of anti-IFN-g antibodies. Viable cells were counted before plating and
after 48 and 96h. The means and SD are shown for each determination and results are representative of two or more independent experiments.
Brieﬂy, p-value was calculated at 96h using two-tailed unpaired Student’s t-test.
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population of IFN-g-producing T cells, this source of IFN-g will
convert naı ¨ve T cells into a T-bet-expressing population that
would obscure the effects of ectopically introduced T-bet. We
were also concerned that splenocytes, the source of CD8
1 T cells
for these studies, may contain IL-12-producing cells that would
promote the expression of T-bet. By including neutralising
antibodies to these two cytokines, IFN-g and IL-12, we were able
to generate replicating CD8
1 T cells that did not express
endogenous T-bet after transduction with the control pMig
retrovirus, and have an experimental system that could evaluate
the effects of this transcription factor.
The capacity of CD8
1 T cells expressing ectopic T-bet at
physiological levels to acquire the effector functions of producing
IFN-g [17] and expressing FasL [19] indicates that these known
effects of this transcription factor occur independently of the
cytokines that normally induce its expression. T-bet expression
alone also accounted for down-regulation of CD127 and SOCS-1
and up-regulation of CD122 and IL-15Ra, thereby switching the
dependence for survival signals from IL-7 to IL-15. These ﬁndings
are consistent with reports that T-bet expression selects against
the differentiation of central memory CD8
1 T cells [6, 7], which
are characterized by the expression of CD127.
T-bet expression alone, however, did not induce the tran-
scription of Blimp-1. Therefore, the development of the termin-
ally differentiated CD8
1 T cell, as represented by the expression
of Blimp-1, can be separated from the acquisition of effector
function, as has been recently emphasized by following the fate of
cells that had expressed granzyme B during a viral infection [20].
Nevertheless, T-bet is linked to Blimp-1 in that it enables a high
level of IL-2R signalling to induce Blimp-1. These observations
may explain the ﬁndings of in vivo studies that sustained IL-2R
signalling, T-bet and Blimp-1 each cause a similar phenotype of
impaired proliferation and high Blimp-1 expression in CD8
1
T cells that has been associated with the ‘‘exhausted’’ [15],
‘‘unhelped’’ [7] or ‘‘terminally differentiated’’ [8, 9] state. Each of
these stages of development may be a manifestation of Blimp-1
expression, which augments effector function but is antithetical
to continued participation of the CD8
1 T cell in vigorous and
rapid clonal expansion [13, 14]. Thus, T-bet alone in the presence
of a low level of IL-2 signalling sufﬁces for the acquisition of
effector functions, but the requirements for T-bet to promote
terminal differentiation are more stringent, perhaps because this
developmental step may be accompanied by loss of expression of
Bmi-1 and the occurrence of replicative senescence [21].
Materials and methods
Mice
C57BL/6 mice were purchased from Charles River UK Limited
(Margate, UK). OT-I RAG
/ mice were a generous gift from C.
Reis e Sousa (Cancer Research UK London Research Institute, UK).
Mice were housed under speciﬁc pathogen-free conditions at the
University of Cambridge. For all animals, housing and procedures
were carried out in accordance to the UK Home Ofﬁce guidelines.
Puriﬁcation and stimulation of primary CD81 T cells
Naı ¨ve CD8
1 OT-I T cells were puriﬁed using negative selection
with the CD8a
1 T-cell Isolation Kit (Miltenyi Biotec) followed by
positive selection with CD62L microbeads (Miltenyi Biotec).
Transduced cells were puriﬁed by staining with anti-Thy1 APC
antibody (clone HIS51, eBioscience) followed by positive selection
with anti-APC microbeads (Miltenyi Biotec). Cells were stimulated
with anti-CD3e clone 145-2C11 (eBioscience), either platebound
(0.5mg/mL), or with the OT-I TCR-speciﬁc antigen, SIINFEKL
peptide (10nM) (Peptides International) [22], in the presence of
mouse IL-2 (2ng/mL) (R&D Systems). Where indicated cell
cultures were continued in IL-2 (2–20ng/mL) or IL-15 (2–20ng/
mL). In conditions where neutralisation of IL-12, IFN-g or Fas-FasL
signalling was indicated, anti-FasL (clone MFL3) at 10–20mg/mL,
anti-IL-12 (clone C17.8) at 5mg/mL, anti-IFN-g (clone XMG1.2) at
5mg/mL or anti-IFN-gR1 (R&D Systems) at 5mg/mL were added.
Flow cytometry
Intracellular staining for IFN-g was performed using the Cytoﬁx/
Cytoperm kit (BD Biosciences) after stimulation with SIINFEKL
peptide (10nM) for 4h. Annexin V and 7-AAD staining (Annexin V
Apoptosis Detection Kit, BD Pharmingen) were performed accord-
ing to the manufacturer’s instructions. Antibodies used were anti-
CD8a (53-6.7), anti-CD44 (IM7), anti-CD62L (MEL-14), anti-CD3e
(145-2C11), anti-IFN-g (XMG1.2), anti-CD127 (A7R34), anti-
CD122 (5H4), anti-KLRG1 (2F1), anti-CD90.1 (HIS51), anti-
IL-15Ra (FAB551F) and anti-FasL (MFL3) (all eBioscience).
Figure 4. T-bet and regulation of IL-2-dependent Blimp-1 transcription.
OT-I cells were transduced, puriﬁed and cultured with 2ng/mL IL-2 or
20ng/mL IL-2 in the presence of neutralising anti-IFN-g, anti-IFN-gR1
and anti-IL-12 antibodies. After 48h, RNA was extracted and assessed
for Blimp-1 mRNA by qRT-PCR relative to CD3e mRNA levels. All RNA
samples were done in triplicate and the ‘‘No RT’’ controls were
negative. Means and SD are shown from a representative of two
independent experiments each with three treatment replicates. Brieﬂy,
p-values were determined by a one-way analysis of variance followed
by Tukey’s multiple comparison test for comparisons between all pairs
of conditions.
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The retroviral vector, pMig and the pCL-ECO packaging construct
have been described previously [23]. Full-length T-bet cDNA was
inserted into the pMig retroviral vector employing XhoI and
EcoRI restriction enzyme sites, which had been modiﬁed by
inserting Thy1 instead of EGFP downstream of the internal
ribosome entry site (IRES) sequence. Moloney murine leukaemia
virus expressing rat Thy1 alone (pMig-IRES-Thy1) or with T-bet
(pMIG-T-bet-IRES-Thy1) was produced by transiently transfect-
ing HEK293 cells at 90% conﬂuency with an equimolar ratio of
pMIG and the packaging construct, pCL-ECO with lipofectamine
2000 (Invitrogen). Primary CD8
1 T cells were transduced 24h
after activation in the presence of IL-2, anti-IFN-g, anti-IFN-gR1,
anti-IL-12 and 6mg/mL protamine sulphate (Sigma).
Quantitative RT-PCR
Primers and TaqMan probes for the detection of murine
Blimp1 (Mm00476128_m1), CD3e (Mm00599683_m1), FasL
(Mm00438864_m1), T-bet (Mm00450960_m1) and SOCS-1
(Mm00782550_s1) were purchased as Assays-on-Demand from
Applied Biosystems.
Western blot analysis
The antibodies used for immunoblot analysis of T-bet expression
were mouse anti-T-bet antibody [4B10] (Santa Cruz Biotechnol-
ogy), goat anti-mouse IgG1-HRP (Santa Cruz Biotechnology),
rabbit anti-b-actin (Abcam), goat anti-rabbit IgG-HRP (Santa Cruz
Biotechnology). Blots were developed with SuperSignal West Pico
Chemiluminescent Substrate (Pierce) and membranes were
stripped using Restore Western Blot Stripping Buffer (Pierce).
MHV-68 infection
The murine gammaherpes virus expressing OVA, MHV-68, was a
generous gift from Professor Philip Stevenson (Division of
Virology, Department of Pathology, University of Cambridge,
Cambridge, UK) [24]. Virus stocks were grown and titered on
BHK-21 cells as has been described previously [25]. C57BL/6
mice were infected intranasally with 210
4pfu of MHV-68.
Splenocytes were either depleted of B cells with anti-CD19
microbreads (Miltenyi Biotec), and CD8
1 CD44
lo, CD44
hi
KLRG1
hi and CD44
hi KLRG1
lo were sorted (Daco MoFlo) after
staining with appropriate monoclonal antibodies.
Statistical analysis
All statistical analyses were performed using the Graphpad Prism
5 program and p-values o0.05 were considered signiﬁcant. For
comparisons between three or more conditions, p-values were
determined by a one-way analysis of variance followed by
Tukey’s multiple comparison test for comparisons between all
pairs of conditions. For comparisons between two conditions,
p-values were determined by two-tailed paired or unpaired
Student’s t-tests.
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